Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
2006-09-19
2006-09-19
Berch, Mark L. (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
active
07109330
ABSTRACT:
Compounds of the following formula are provided:In the Formula (I), R1is —X—R1′; in which R1′ is optionally substituted lower alkyl, optionally substituted aryl, optionally substituted heteroaryl, or optionally substituted heterocyclyl, and X is —NH—. R2is lower alkyl optionally substituted with one, two or three groups chosen from hydroxy, lower alkoxy, and halogen. And R3is —NR4R5; in which R4is hydrogen and R5is lower alkyl substituted with amino; or (ii) R4and R5are both lower alkyl optionally substituted with one, two or three groups chosen from hydroxy and amino. It is to be understood that R1′ is not cyclohexylmethyl, phenyl, substituted phenyl, benzyl, phenylethyl, or m-hydroxybenzyl. The compounds inhibit CDK-2 activity and are useful for treating disorders characterized by undesirable cell proliferation.
REFERENCES:
patent: 5866702 (1999-02-01), Mackman et al.
patent: 6303618 (2001-10-01), Griffin et al.
patent: 6316456 (2001-11-01), Meijer et al.
patent: 6498163 (2002-12-01), Boschelli et al.
patent: 6767906 (2004-07-01), Imbach et al.
patent: 6794390 (2004-09-01), Lum et al.
patent: 6803371 (2004-10-01), Gray et al.
patent: 2005/0009846 (2005-01-01), Fischer et al.
patent: WO 97/16452 (1997-05-01), None
Vesely, Eur. J. Biochem. 224, 771 (1994).
Glab, FEBS Letters 353, 207 (1994).
Abraham, Biol Cell 83, 105 (1995).
Schultz-Gahmen, Proteins: Structure, function and Genetics 22, 378 (1995).
Schow, Biorganic & Medicinal Chemistry Letters 7(21) 2967, 1997.
Kenneth A. Jacobson, J Med. Chem 38(10) pp. 1720-1735 (1995).
Thais M. Sielecki, J. Med. Chem.; 2000; 43(1) pp. 1-18.
Blum Cheri Lynn
Ibrahim Prabha
Lum Robert
Mackman Richard
Schow Steven
Berch Mark L.
CV Therapeutics Inc.
CV Therapeutics, Inc.
LandOfFree
Purine inhibitors of cyclin dependent kinase 2 and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Purine inhibitors of cyclin dependent kinase 2 and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purine inhibitors of cyclin dependent kinase 2 and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3577804